Decreased vesicular acetylcholine transporter related to memory deficits in epilepsy: A [18F] VAT positron emission tomography brain imaging study. (20th August 2018)

• Record Type: Journal Article
• Authors: Wu, Xu‐Qing; Zhao, Ya‐Nan; Ding, Jing; Si, Zhan; Cheng, Deng‐Feng; Shi, Hong‐Cheng; Wang, Xin
• Is Part Of: Epilepsia. Volume 59:issue 9(2018)
• Page Start: 1655
• Page End: 1666
• Publication Date: 2018-08-20
• Subjects: epilepsy -- memory deficit -- positron emission tomography -- vesicular acetylcholine transporter; Epilepsy -- Periodicals; 616.853
• DOI: 10.1111/epi.14533
• Languages: English
• ISSNs: 0013-9580

Abstract

Summary: Objective: Vesicular acetylcholine transporter (VAChT) is a rate‐limiting factor for synaptic acetylcholine transport. Our study focused on whether [ 18 F] VAT, a novel positron emission tomography (PET) tracer, could be used in detecting cognitive deficits in epilepsy. Methods: Morris water maze test was used to evaluate learning and memory deficits in pilocarpine‐induced chronic epilepsy rats 12 weeks after status epilepticus. Interictal [ 18 F] VAT PET was performed 13 weeks after status epilepticus to evaluate the level of VAChT in cholinergic pathways compared with [ 18 F] fluorodeoxyglucose PET. The association between VAChT levels and memory measures was analyzed. Neuropathological tests were performed. Results: Epileptic rats exhibited significant memory deficits in Morris water maze test. [ 18 F] VAT uptake decreased in septum, hippocampus, thalamus, and basal forebrain, and correlated to memory function. Of note, the level of VAChT in basal forebrain significantly decreased, yet no glucose hypometabolism was detected. Immunofluorescence and Western blot demonstrated decreased expression of VAChT in hippocampus and basal forebrain in the epilepsy group, but no change of expression of acetyltransferase or activity of acetylcholinesterase was detected. Significance: [ 18 F] VAT PET is a promising method to test the level of VAChT as a valuable biomarker for memory deficits in pilocarpine‐induced chronic epileptic rats.